Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Andreevna Kuzmina
Observed names:
E. A. Kuzmina,
E. Kuzmina,
Elena A. Kuzmina,
Elena Kuzmina
Institution:
National Medical Research Center for Hematology
Observed institutions:
Rabin Medical Center,
National Medical Research Center for Hematology,
Ministry of Health of the Russian Federation,
Versiti Blood Research Institute Foundation,
All India Institute of Medical Sciences
ORCID:
0000-0002-9181-6050
Observed ORCID:
0000-0002-9181-6050
OpenAlex ID:
A5103068256
P708: Canadian and Russian Experiences of Asciminib in Chronic Myeloid Leukemia (cml) Patients Who Failed Multiple Lines of Tyrosine Kinase Inhibitor (tki) Therapy.
2022
·
F. Khadadah
, A. G. Turkina
, et al.
·
HemaSphere
·
9
The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in Russia
2023
·
Elena Kuzmina
, Ekaterina Chelysheva
, et al.
·
Blood
·
5
Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia
2022
·
Anna Turkina
, Elena A. Kuzmina
, et al.
·
Blood
·
4
Treatment Outcomes with Asciminib, the First Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor, in Chronic Myeloid Leukemia Patients with Multiple Resistance to Prior Therapy
2023
·
A. G. Turkina
, Elena Andreevna Kuzmina
·
Clinical oncohematology
·
3
PDF
Results of asciminib therapy as part of managed access program in patients with chronic myeloid leukemia with T315I mutation
2025
·
A. N. Petrova
, E. G. Lomaia
, et al.
·
Oncohematology
·
2
PDF
Allele-Specific PCR for Detection of Missense Mutations in the Chimeric BCR::ABL1 Gene Causing Failure of Tyrosine Kinase Inhibitor Therapy in CML Patients
2025
·
Anastasia Skripkina
, Irina Fevraleva
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
P718: Asciminib Managed-access Program (map) in Russia
2022
·
O. Shukhov
, A. Turkina
, et al.
·
HemaSphere
·
2
Results of the Molecular Response Evaluation and TKI Dose Adjustment in Chronic Myeloid Leukemia Patients in Prospective Study of Reduction and Discontinuation Treatment of TKI (READIT)
2024
·
Oleg Shukhov
, Margarita Gurianova
, et al.
·
Blood
·
1
Interim Results of the Russian Prospective Multi-Center Clinical Trial READIT-2020 (Reduction of Tyrosine Kinase Inhibitor Doses in CML Patients, Plasma Imatinib/Nilotinib Concentrations, Sustaining Molecular Response, and Drug Toxicity)
2024
·
Margarita Anatolevna Gurianova
, V. I. Kazey
, et al.
·
Clinical oncohematology
·
1
PDF
P673: Asciminib Managment in Chronic Myeloid Leukemia (cml) Patients With T315i Mutation.
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
HemaSphere
·
1
A long-term follow-up of observation in treatment-free remission in patients with chronic myeloid leukemia
2023
·
A. N. Petrova
, E. Yu. Chelysheva
, et al.
·
Гематология и трансфузиология
·
1
PDF
POSTER: CML-1134: Efficacy and Safety of Asciminib Dose Escalation in Patients With Chronic Myeloid Leukemia Without Optimal Response to the Standard Dose
2026
·
Elza Lomaia
, Elena Morozova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-1134: Efficacy and Safety of Asciminib Dose Escalation in Patients With Chronic Myeloid Leukemia Without Optimal Response to the Standard Dose
2026
·
Elza Lomaia
, Elena Morozova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Somatic mutations in cancer-related genes in chronic myeloid leukemia patients receiving asciminib
2025
·
Elena Kuzmina
, Ekaterina Chelysheva
, et al.
·
Blood
POSTER: CML-598 Clinical Significance of Somatic Mutations in Chronic Myeloid Leukemia Patients on Asciminib Therapy
2025
·
Elena Kuzmina
, E Chelysheva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-598: Clinical Significance of Somatic Mutations in Chronic Myeloid Leukemia Patients on Asciminib Therapy
2025
·
Elena Kuzmina
, E Chelysheva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
The Role of Somatic Mutations in Various Genes and the Issue of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: A Literature Review
2025
·
Elena Andreevna Kuzmina
, E. Yu. Chelysheva
, et al.
·
Clinical oncohematology
PDF
Results of various somatic mutations detection in patients with chronic myeloid leukemia
2024
·
E. A. Kuzmina
, E. Yu. Chelysheva
, et al.
·
Oncohematology
PDF
CML-585 Mutational Landscape of Tumor Cells in Patients With Chronic Myeloid Leukemia
2024
·
Elena Kuzmina
, Ekaterina Chelysheva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Mutational Landscape of Tumor Cells in Patients With Chronic Myeloid Leukemia
2024
·
Elena Kuzmina
, Ekaterina Chelysheva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-250 The Prognostic Factors of Late Molecular Relapses after Treatment Discontinuation in Patients With Chronic Myeloid Leukemia
2023
·
Anna Petrova
, Oleg Shukhov
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-250 The Prognostic Factors of Late Molecular Relapses after Treatment Discontinuation in Patients With Chronic Myeloid Leukemia
2023
·
Anna Petrova
, Oleg Shukhov
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Pb1975: Abl1 Gene Dna Sequencing in Patients With Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia.
2023
·
Elena Kuzmina
, Bella Biderman
, et al.
·
HemaSphere
Show more works
View as search
Works count:
28
Citation count:
31
H-index:
3
I10-index:
Year
Topic
Type